Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 24,861 | 31,796 | 24,447 | 57,492 | 16,427 |
| Cost of Goods | 3,494 | 4,717 | 4,289 | 9,778 | 2,751 |
| Gross Profit | 21,367 | 27,079 | 20,158 | 47,714 | 13,676 |
| Operating Expenses | 35,574 | 55,077 | 34,164 | 34,403 | 28,648 |
| Operating Income | -13,713 | -27,281 | -13,717 | 14,089 | -14,221 |
| Interest Expense | 4,479 | 4,390 | 4,367 | 4,344 | 4,307 |
| Other Income | 282 | 18 | -118 | -28 | 182 |
| Pre-tax Income | -17,910 | -31,653 | -18,202 | 9,717 | -18,346 |
| Net Income Continuous | -17,910 | -32,253 | -18,202 | 9,717 | -18,346 |
| Net Income | $-17,910 | $-32,253 | $-18,202 | $9,717 | $-18,346 |
| EPS Basic Total Ops | -0.35 | -0.66 | -0.37 | 0.20 | -0.39 |
| EPS Basic Continuous Ops | -0.34 | -0.66 | -0.37 | 0.21 | -0.39 |
| EPS Diluted Total Ops | -0.35 | -0.66 | -0.37 | 0.20 | -0.39 |
| EPS Diluted Continuous Ops | -0.34 | -0.66 | -0.37 | 0.20 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.64 | -0.37 | N/A | N/A |
| EBITDA(a) | $-13,569 | $-27,202 | $-13,630 | $14,204 | $-14,111 |